Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FB2MT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,439
Award facts
- Contract value 100% obligated
- $23,439.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 13, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Gemtesa 75 mg tablets in quantities of 90 units at a firm fixed price of $23,439.20, with completion targeted for January 14, 2026. The award was made on a full and open competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The awardee operates as a subsidiary of Cencora, Inc., which does business as AmerisourceBergen.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. The IDC enables the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Through this vehicle and other federal contracts, AmerisourceBergen consistently demonstrates its capability to meet the Defense Logistics Agency's pharmaceutical supply requirements for the Department of Defense, Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FB2MT?
SPE2DR26FB2MT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FB2MT worth?
The government has obligated $23,439 on SPE2DR26FB2MT.
Is contract SPE2DR26FB2MT an order under another contract?
Yes. SPE2DR26FB2MT is a delivery order under SPE2DR25D2102, an indefinite delivery contract.
Was contract SPE2DR26FB2MT competed?
The extent of competition for SPE2DR26FB2MT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award